Meta Analysis for Effectiveness of RFX for Primary and Secondary Prevention. by Yangyang Hu (3309009)

Subjects:

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Subjects:

Learn!Bio study: Grouping of Participants. by Katy Andrews (22311170)

Subjects:

Summary of the screened symptoms at baseline (t0) for completers (n = 160). by Anton Kurapov (11346019)

Subjects:

Summary of the program evaluation. by Anton Kurapov (11346019)

Subjects:

Changes in continuous sleep measures from pre (t1) to post (t2) intervention. by Anton Kurapov (11346019)

Subjects:

Overview over the contents of the app program divided by level [28]. by Anton Kurapov (11346019)

Subjects:

Sociodemographic information, participant flow, engagement, and compliance. by Anton Kurapov (11346019)

Subjects:

Changes in mental health symptoms after the sleep intervention (n = 160 completers). by Anton Kurapov (11346019)

Subjects:

‘Sleep2Ukraine’ study design. by Anton Kurapov (11346019)

Subjects:

Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

Subjects:

Summary of significance levels for comparison of surgical segment ROM between different test groups. by Jia Zhu (135506)

Subjects:

Distinct and shared gene expression patterns among leukemia cell lines following EF-24 treatment. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment alters gene expression profiles in HL-60 cells. by Ajeet P. Singh (22298432)

Subjects:

Expression analysis of downstream target genes in the IL-10 signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment modulates gene expression in THP-1 cells. by Ajeet P. Singh (22298432)

Subjects:

Expression analysis of downstream target genes in the p38/MAPK signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. by Ajeet P. Singh (22298432)

Subjects:

Analysis of the Nugent score before (T=0) and after (T=1) the use of the vaginal gel. Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047). by Adriana Bittencourt Campaner (21175462)

“…Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047).…”